AAAAAA
Results:
1-8
|
Results: 8
Authors:
Dhainaut, JF
Giroir, B
Opal, S
Citation: Jf. Dhainaut et al., Introduction to the second Margaux Conference on Critical Illness sepsis: Interface between inflammation, coagulation, and the endothelium, CRIT CARE M, 29(7), 2001, pp. S1-S1
Authors:
Cohen, J
Guyatt, G
Bernard, GR
Calandra, T
Cook, D
Elbourne, D
Marshall, J
Nunn, A
Opal, S
Citation: J. Cohen et al., New strategies for clinical trials in patients with sepsis and septic shock, CRIT CARE M, 29(4), 2001, pp. 880-886
Authors:
Luchi, M
Morrison, DC
Opal, S
Yoneda, K
Slotman, G
Chambers, H
Wiesenfeld, H
Lemke, J
Ryan, JL
Horn, D
Citation: M. Luchi et al., A comparative trial of imipenem versus ceftazidime in the release of endotoxin and cytokine generation in patients with Gram-negative urosepsis, J ENDOTOX R, 6(1), 2000, pp. 25-31
Authors:
Gluck, T
Opal, S
Alattar-Mantis, J
Weitzel, T
Lode, H
Scholmerich, J
Citation: T. Gluck et al., Differences between American and German medical students and physicians inknowledge of infectious diseases, EUR J CL M, 19(11), 2000, pp. 868-870
Authors:
Bernard, G
Opal, S
Marshall, J
Citation: G. Bernard et al., Therapeutic rationale for antithrombin III in sepsis - Question and answersession after scientific review, CRIT CARE M, 28(9), 2000, pp. S37-S37
Authors:
Vincent, JL
Fourrier, F
Opal, S
Citation: Jl. Vincent et al., Clinical trial results with antithrombin III in sepsis - Question and answer session after scientific review, CRIT CARE M, 28(9), 2000, pp. S43-S43
Authors:
Opal, S
Fisher, C
Vincent, JL
Citation: S. Opal et al., Protein C levels as a prognostic indicator of outcome in sepsis and related diseases - Question and answer session after scientific review, CRIT CARE M, 28(9), 2000, pp. S56-S56
Authors:
Opal, S
Thijs, L
Cavaillon, JM
Cohen, J
Fourrier, F
Citation: S. Opal et al., Roundtable I: Relationships between coagulation and inflammatory processes, CRIT CARE M, 28(9), 2000, pp. S81-S82
Risultati:
1-8
|